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The central role of the Golgi apparatus in critical cellular processes such
as the transport, processing, and sorting of proteins and lipids has placed
it at the forefront of cell science. Golgi apparatus dysfunction caused by
primary defects within the Golgi or pharmacological and oxidative stress
has been implicated in a wide range of neurodegenerative diseases. In
addition to participating in disease progression, the Golgi apparatus
plays pivotal roles in angiogenesis, neurogenesis, and synaptogenesis,
thereby promoting neurological recovery. In this review, we focus on
the functions of the Golgi apparatus and its mediated events during
neurorestoration.
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1

Introduction

The Golgi apparatus—a highly dynamic cellular
organelle—functions in the processing and
sorting of proteins and lipids during trafficking
from the endoplasmic reticulum (ER) to different
destinations in the cell [1]. Considering its central
role in the secretory pathway, alterations in the
structure and function of the Golgi apparatus are
anticipated to affect the homeostasis of cellular
proteins and lipids. Increasing evidence suggests
that structural changes and functional disorders
of the Golgi apparatus are involved in many
neurodegenerative diseases [2–4]. However,
whether the Golgi apparatus also participates
in neurorestoration in such diseases remains
unclear. In this review, we describe the central
Corresponding author: Zhiping Hu, E-mail: zhipinghu@csu.edu.cn

roles of the Golgi apparatus in cells and discuss
neurodegenerative diseases associated with
structural changes and functional disorders of
the Golgi apparatus. Finally, we highlight the role
of the Golgi apparatus in neurorestoration.

2

Structure and function of the Golgi
apparatus

In 1898, the Italian anatomist Camillio Golgi
discovered this cell organelle that now bears his
name—the Golgi complex or apparatus [5]. In
mammalian cells, the Golgi apparatus comprises
dozens of flattened, parallel, interconnected
cisternae. The pile of Golgi cisternae is referred
to as the Golgi stack. Based on the distribution
of resident proteins, the Golgi stacks can be
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divided into three functional compartments: cis-,
medial-, and trans-Golgi cisternae [1]. The Golgi
stacks are connected to the cis- and trans-Golgi
networks (CGN and TGN, respectively). CGN
is connected to the first cis-Golgi cisterna [6]
and is involved in ER–Golgi trafficking. TGN is
involved in the sorting of cargos to their final
destination.
The Golgi apparatus is the central hub of
the secretory pathway [7]. The main secretory
pathway can be divided into the following steps.
First, newly synthesized proteins or lipids enter
the exit sites of ER and are sorted into budding
vesicles that depending on the membrane-bending
properties of coat protein complex II. Second,
vesicles move to the ER–Golgi intermediate compartment and forward to CGN. Third, proteins
or lipids enter the cis-Golgi cisternae and move
toward the trans-Golgi cisternae. Finally, vesicles
reach TGN, which is involved in protein
glycosylation and sorting of cargos to their final
destination, such as lysosomes, endosomes, or
the plasma membrane.
Vesicular transport and cisternal maturation are
the two classical models of intra-Golgi transport.
In this review, we focus on the cisternal
maturation model. This model proposes that the
Golgi cisternae are dynamic structures that shift
from the cis-toward the trans-Golgi side. This
shift can be divided into three stages [8]. At the
cisternal assembly stage (which involves ERGIC
and cis-Golgi cisternae), ER-derived COPII vesicles
deliver cargo to a cisterna and are balanced
by a retrograde-directed pathway that recycles
machinery proteins to ER in COPI vesicles.
Next, at the carbohydrate synthesis stage (which
involves medial and trans-cisternae), cisternae
exchange cargo with other cisternae via COPI
vesicles. Finally, at the carrier formation stage
(which involves TGN), cisternae produce clathrincoated vesicles while receiving incoming material
from endosomes.
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3

Structural and functional changes of the
Golgi apparatus in neurodegenerative
disease

The Golgi apparatus is a highly organized subcellular organelle that acts as a cellular sensor,
adapting and changing its structure depending
on the physiological state of the cell. Structural
changes of the Golgi apparatus result in the
dispersal or complete disassembly of the Golgi
stacks, forming a fragmented Golgi apparatus
in a process termed Golgi fragmentation. Cell
apoptosis can result in Golgi fragmentation, as
demonstrated in an in vitro model of mechanical
cell injury [9]. However, Golgi fragmentation often
represents an early causative event rather than a
secondary step before cell apoptosis [10, 11].
Under pharmacological or oxidative stress, several
changes occur in the Golgi apparatus, such as
cargo overloading, ionic imbalance, and perturbation of glycosylation and luminal pH [12–14].
These changes can lead to insufficient Golgi
glycosylation and Golgi-mediated membrane
trafficking (Golgi stress). The Golgi stress response
represents autoregulation to repair the Golgi
apparatus and may initiate signaling pathways to
alleviate stress. Nuclear signaling pathways of the
Golgi stress response have been demonstrated
[15–17]. In the procaspase-2/golgin-160 pathway,
procaspase-2 interacts with upstream apoptotic
regulators and mediates the cleavage of Golgi
matrix proteins such as golgin-160 and giantin,
which generally exhibit nuclear localization
signals. Nuclear fragments of Golgi matrix
proteins enter the nucleus and participate in
the stress repair pathway. Moreover, in the TFE3
pathway, dephosphorylation and nuclear translocation of TFE3 result in the transcription of
Golgi apparatus stress element-containing genes,
which increase the levels of Golgi glycosylation
enzymes and trafficking components. Furthermore,
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in the HSP47 pathway, HSP47 downregulation
leads to Golgi fragmentation and Golgi stressinduced apoptosis. In the CREB3/ARF4 pathway,
ARF4 is localized to the Golgi membranes and
regulates Golgi-to-ER trafficking; when ARF4
is downregulated under Golgi stress, CREB3
is activated and translocated to the nucleus,
upregulating ARF4 transcription. If these pathways
fail to repair overstimulation, the Golgi is completely disassembled, inducing cell apoptosis.
Structural changes of the Golgi apparatus
are typical of many neurodegenerative diseases,
such as amyotrophic lateral sclerosis [2, 18, 19],
Alzheimer’s disease [3], Parkinson’s disease [4],
Huntington’s disease [20], Creutzfeldt–Jacob
disease [21], and multiple system atrophy [22].
Golgi fragmentation has been proposed to be
a late event in cellular apoptosis. Meanwhile,
Golgi fragmentation has been reported to occur
before microtubule degeneration and may be a
trigger for neuronal loss [23]. In the pathology of
neurodegenerative diseases, the Golgi apparatus
initially appears to exhibit an adaptive response,
such as compensatory expansion. However, when
neurons are overstimulated by excitotoxins and
oxidative insults, the Golgi apparatus gradually
appears to disperse and undergo atrophy [24].
Mechanisms of neuronal Golgi fragmentation
involved in the pathogenesis of neurodegenerative
diseases include the (1) impairment of endosometo-Golgi retrieval of membrane proteins [25];
(2) disruption of ER-to-Golgi trafficking by mutant
growth hormones [26]; and (3) interruption of the
ER–lysosome–Golgi network, which is important
for protein glycosylation [27]. Normal Golgi
glycosylation assists in protein folding, making
intermediates more hydrophilic, which may
prevent mutant protein aggregation—a crucial
cascade event for neurodegeneration. The inhibition of neuronal Golgi fragmentation decreases
or delays cell apoptosis [28], indicating that
fragmentation of the neuronal Golgi apparatus

is a key contributor to neuronal cell apoptosis
and neurodegeneration. The association between
the Golgi apparatus and neurodegenerative
diseases is presented in Fig. 1. Oxidative stress
signals result in Golgi stress and initially elicit
a protective effect. However, overstimulation
shows damaging effects and results in Golgi
fragmentation, which is a positive feedback
module that enhances Golgi stress signaling
and accelerates neuronal dysfunction, ultimately
leading to neurodegeneration.

Fig. 1 Possible links between Golgi stress, Golgi fragmentation, and neurodegeneration. Stress signal enables the
sensing of Golgi stress, which acts as a positive feedback
module that enhances stress signaling. If the stress is very
severe, it contributes to Golgi fragmentation and subsequently
apoptosis, polarized dendrite morphogenesis abnormalities,
axon transport dysfunction, and synapse degeneration,
eventually resulting in neurodegeneration.

4

4.1

Roles of the Golgi apparatus in neurorestoration
Golgi apparatus and neurogenesis

In the adult mammalian brain, neurogenesis
occurs in two neurogenic niches throughout life:
the subventricular zone (SVZ) [29] and the subgranular zone (SGZ) [30]. Adult-born granule
cells are continuously generated in the SGZ of
the hippocampus dentate gyrus [31]. These new
neurons contribute to memory formation and
Journal of Neurorestoratology
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mood regulation [32, 33]. During development,
granule cells bear a single primary dendrite
with branches extending toward the molecular
layer and a long axon projecting through the
hilar area into the CA3 region [34]; the mature
adult-born granule cells are devoid of basal
dendrites. Polarized dendritic establishment is
important for proper formation of neural circuits
and signal integration [35]. Accumulating evidence
suggests that the development of polarized
dendrites in adult-born granule cells is related
to the Golgi apparatus. By analyzing the Golgirelated genes of adult-born granule cells, a study
found that STK25 and STRAD regulate neuronal
development. Knockdown of these two proteins
could result in aberrant dendrite establishment
[36]. In the dentate gyrus of 8-week-old mice,
the Golgi apparatus is predominantly located
in the initial segment of the primary dendrite.
Downregulation of the Golgi matrix protein
GM130 or overexpression of GRASP65 in the
dentate gyrus could disrupt Golgi deployment,
potentially affecting the initiation and extension
of dendrites [37]. Thus, the polarized distribution
of the Golgi apparatus is essential for dendrite
polarity in adult-born hippocampal granule cells.
The Golgi apparatus associates with adult-born
dentate granule cells in SGZ and also contributes
to the identity and cytoarchitecture of neural
stem and progenitor cells in SVZ and ventricular
zone [38]. Moreover, the polarized architecture of
neural stem cells is related to asymmetric Golgi
subcellular localization [39]. In bipolar epithelial
neural stem cells, the Golgi apparatus shows very
specific and noncanonical features [40].
Reelin [41–43], liver kinase B1 (LKB1) [36, 37],
PITPNA/PITPNB [44], STK25 [36], and Brefeldin
A-inhibited guanine exchange factor 2 (BIG2) [45]
regulate Golgi subcellular localization. Figure 2
illustrates the related signaling pathways contributing to polarized dendrite morphogenesis in
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adult-born neurons. The mechanism of polarized
Golgi distribution contributing to dendrite
polarity may be related to the polarized postGolgi membrane trafficking. The Golgi-mediated
membrane trafficking pathways deliver proteins
from the soma to dendrites, and the blockade of
ER-to-Golgi trafficking could suppress dendritic
growth [46]. Protein kinase D (PKD)1 and PKD2,
which are required for the post-Golgi trafficking,
regulate the directionality of Golgi-derived
vesicles [47, 48]. The loss of function of PKD1
and PKD2 in the hippocampal neurons results
in the mislocalization of axon-specific vesicles
sorted by TGN, thus converting pre-existing
dendrites into axons [49]. In normal hippocampal
neurons, the post-Golgi membrane trafficking is
preferentially directed toward a single principal
dendrite, indicating an association between
asymmetric Golgi apparatus distribution and
dendritic outgrowth [50]. Therefore, malformation

Fig. 2 Signaling pathways regulating Golgi distribution
and neuronal polarity during neurogenesis. (1) STK25 and
Mst4, downstream effectors of LKB1, co-immunoprecipitate
with STRAD and bind to the Golgi matrix protein GM130.
These two effectors are enriched in the Golgi apparatus
and essential for Golgi organization. (2) The lipid transfer
proteins (PITPNA/PITPNB) potentiate the PI4P-dependent
recruitment of GOLPH3 to the Golgi apparatus, which
promotes MYO18A-directed localization of the Golgi to the
apical compartment. (3) Reelin and Dab1 regulate Golgi
extension into the apical process of pyramidal neurons.
(4) BIG2–ARF1–RhoA–mDia1 signaling regulates dendritic
Golgi deployment and dendrite growth in adult newborn
hippocampal neurons.
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of Golgi structure and localization during neurogenesis could inflict structural and functional
damage to nascent neurons.
4.2

Golgi apparatus and synaptogenesis

The formation and stabilization of synapses in
the central nervous system involve a complex
process including several precise steps. The initial
stage of synaptogenesis involves the delivery of
some proteins and lipids to the site of contact
between the axons and dendrites. This process is
mediated by vesicular carriers that fuse with the
synaptic plasma membrane to deliver synaptic
receptors. The Golgi apparatus, the main station
for the modification, maturation, and sorting of
proteins, plays an important role in the delivery
of synaptic proteins. When a vesicle exiting the
Golgi apparatus is impaired, the transport of
prototypic active zone cytomatrix molecules out
of the soma is inhibited [51]. TGN-derived
carriers are important vehicles for the transport
and release of synaptic proteins to the synaptic
contact sites [52]. In addition to being a singlecopy perinuclear organelle in the soma in most
mammalian cells, the neuronal Golgi apparatus
includes satellite Golgi outposts (GOPs) in
dendrites as an extension of the somatic Golgi
apparatus. In cultured hippocampal neurons,
GOPs localize predominantly to the dendritic
branchpoints and are typically present in the
first-order segment of the apical dendrite [50].
Evidence suggests that GOPs are essential for the
membrane trafficking of receptors to synapses
[53]. Through live-cell imaging, the involvement
of GOPs in the trafficking of membrane proteins
and secreted neuronal growth factors was demonstrated [54]. A recent review has illustrated
the proteins associated with GOPs, such as
the kainate receptor GluK2, synapse-associated
protein 97, and N-methyl-D-aspartate receptor
[55]. Impaired GOPs contribute to decreased
GOP synthesis and plasma membrane protein

supply [56].
In cultured neurons, piccolo and bassoon
co-localize with markers of TGN. Impairing the
Golgi-binding region and blocking Golgi-derived
vesicle formation can reduce bassoon levels at
synapses [51]. In the cerebellum of GM130-KO
mice, the soma-to-dendritic trafficking of postsynaptic density protein 95 was reduced, which
can cause reduced neurotransmitter receptor
abundance [57]. Thus, maintaining the normal
structure and function of the Golgi apparatus
is essential for synaptic proteins membrane
trafficking.
4.3

Golgi apparatus and angiogenesis

Angiogenesis—the formation and maintenance
of blood vessel architecture—plays critical
roles in the recovery of cerebrovascular disease.
Vascular endothelial growth factor (VEGF) is a
primary driver of angiogenesis. During vascular
tube formation, VEGF regulates endothelial cell
proliferation and migration. Vascular endothelial
growth factor receptor 2 (VEGFR2), the primary
cognate receptor of VEGF, is expressed in
endothelial cells and mediates signaling pathways
to promote angiogenesis [58]. Given the importance of VEGFR2 in blood vessel formation,
regulating VEGFR2 expression is a primary
means of controlling angiogenesis. Brefeldin
(a fungal metabolite that disrupts ER-to-Golgi
membrane trafficking) can evidently reduce the
levels of endothelial cell surface VEGFR2. Thus,
the delivery of newly synthesized VEGFR2 from
the Golgi apparatus to the endothelial plasma
membrane is an important limiting mechanism
in VEGFR2 expression [59].
Before VEGF stimulation, VEGFR2 in endothelial cells is localized in the Golgi apparatus.
Several studies have investigated the molecular
machinery required for VEGFR2 trafficking from
the Golgi apparatus to the plasma membrane
(Table 1). Syntaxin 6, a member of the soluble
Journal of Neurorestoratology
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Table 1

Golgi apparatus-related molecular machinery regulating VEGFR2 expression in angiogenesis.

Molecules

In vivo model

Syntaxin 6 Syntaxin
6-cyto-treated
mouse ear

Syntaxin NA
16

Myosin 1c NA

KIF13B
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In vitro model

Association with the Golgi
apparatus

Function in
angiogenesis

Reference

Syntaxin 6-deficient Inhibiting syntaxin 6 increase
HUVEC
VEGFR2 trafficking from
Golgi to the lysosomes for
degradation, without the
inhibition of VEGFR2 synthesis

Syntaxin 6 deletion reduces
plasma membrane and total
cellular VEGFR2 expression
and blocks angiogenesis

[59]

LDL-exposed
HUVEC

Syntaxin 16 deletion increases
total cellular VEGFR2
expression and may promote
angiogenesis

[61]

Myosin 1c deletion reduces
plasma membrane and total
cellular VEGFR2 expression
and blocks angiogenesis

[62]

KIF13B deletion reduces
VEGFR2 plasma membrane
expression and blocks
angiogenesis

[64]

Regulates endosome–transGolgi network trafficking of
VEGFR2

Myosin 1c-deficient Myosin 1c depletion results in
HUVEC
increased VEGFR2 trafficking
from the Golgi to lysosomes
for degradation

Mice injected with KIF13B-knockdown KIF13B interacting with VEGFR2
HUVEC
cargo and microtubules in the
KIF13B-shRNAGolgi initiates VEGFR2
treated Matrigel
trafficking

Src family Diabetic mice
kinases

High-glucoseexposed
HUVEC

Src family kinases reduce cell
Src family kinases mediate
surface VEGFR2 abundance
ROS-induced VEGFR2
phosphorylation, which reduces and block angiogenesis
VEGFR2 abundance in the Golgi

[84]

YAP/TAZ YAP/TAZECKO mice

YAP/TAZ-knockdo
wn HBMEC

YAP/TAZ deletion impairs
VEGFR2 exit from TGN

YAP/TAZ deletion reduces
VEGFR2 plasma membrane
expression and blocks
angiogenesis

[63]

SENP1-deficient
HUVEC

SENP1 deletion induces
VEGFR2 hyper-SUMOylation
and accumulation of VEGFR2
in the Golgi

SENP1 deletion reduces
VEGFR2 plasma membrane
expression and blocks
angiogenesis

[85]

SENP1

SENP1-ECKO
mice

VEGFR2: vascular endothelial growth factor receptor 2; HUVEC: human umbilical vein endothelial cell; LDL: low-density
lipoprotein; ROS: reactive oxygen species; TGN: trans-Golgi network

N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) protein family, is
localized primarily in the Golgi apparatus and
involved in the post-Golgi trafficking of VEGFR2.
Functional inhibition of syntaxin 6 can reroute
VEGFR2 from the plasma membrane to lysosomes
and block VEGF-induced angiogenesis [59].
Syntaxin 16, another member of the SNARE
protein family, is associated with endosometo-TGN retrograde trafficking [60]. In low-densitylipoprotein–exposed endothelial cells, VEGFR2
abundance is markedly reduced, depending on
syntaxin-16-mediated endosome-TGN trafficking
[61]. In addition to syntaxins, myosin 1c (Myo1c)

plays a role in the delivery of a VEGF-induced
secretory VEGFR2 pool from TGN to the plasma
membrane [62]. Myolc expression can be
regulated by YAP/TAZ activity in postnatal brain
endothelial cells. Meanwhile, lack of YAP/TAZ
results in impaired Golgi-to-plasma membrane
trafficking of VEGFR2 [63]. The kinesin-3 protein
KIF13B can bind to VEGFR2 at the Golgi apparatus
and initiate its trafficking to the endothelial cell
surface [64]. Although previous studies confirmed
that the above molecules contribute to VEGFR2
trafficking from the Golgi apparatus, the associations among syntaxin 6, Myo1c, YAP/TAZ,
and KIF13B warrant further exploration.
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5

Role of the Golgi apparatus in neurorestorative therapies

Neurorestoration is supported by a complex
interplay of multiple molecular pathways.
Structural and functional changes of the Golgi
apparatus interrupt the processing, modification,
sorting, and trafficking of proteins and lipids
to their final destination, resulting in a series of
pathological changes during the pathogenesis of
neurodegenerative diseases. A number of molecules target the Golgi apparatus through different
mechanisms. Uncovering the regulatory networks
that target the Golgi apparatus can provide new
therapeutic strategies of neurorestoration. However,
whether these molecules can be applied in the
clinical practice requires further research.
5.1 Therapies aimed at protecting the Golgi
structure
Loss of synapse integrity and function has been
considered a starting point for neuronal loss
and an important early feature in many neurodegenerative diseases. Golgi fragmentation, a
common feature in many neurodegenerative
diseases [65], interrupts the processing and
trafficking of secretory proteins and subsequently
synaptogenesis. Restoration of the Golgi structure may serve as a therapeutic strategy of
neurorestoration.
Under physiological conditions, Cdk5 plays
critical roles in synaptic functions and dendritic
spine formation [66, 67]. In Alzheimer’s disease
models, overactivated Cdk5 alone enhanced
Golgi fragmentation by promoting GM130 and
GRASP65 phosphorylation [68, 69]. The use of
Cdk5 inhibitor peptide rescued Aβ-induced
Golgi disassembly. In addition to Alzheimer’s
disease, Golgi fragmentation plays a role in
isoflurane-related neurotoxicity. Isoflurane is a
widely used anesthetic, which increases the risk
of postoperative cognitive decline in the elderly.

In cultured primary hippocampal neurons, the
proportion of fragmented Golgi increased
following isoflurane treatment, resulting in
significantly decreased neuronal viability [70].
Roscovitine, a Cdk5 inhibitor, shows protective
effects against Golgi fragmentation and isofluranerelated neurotoxicity.
5.2 Therapies aimed at regulating the Golgi
deployment
Dysfunctional Golgi localization during neurogenesis could induce functional damage to nascent
neurons. The regulation of Golgi deployment in
nascent neurons is a potential therapeutic target
for the treatment of neurodegenerative diseases
neurogenesis. The Rho family of small GTPases
(Rho GTPases) plays key regulatory roles in
correct dendrite development, which is essential
for establishing neural circuitry. Accumulating
studies have implicated critical roles of Rho
GTPase-dependent signaling in the regulation of
Golgi polarization and deployment as well as of
neuronal morphogenesis [71, 72]. Cell division
cycle 42 (Cdc42), a small Rho GTPase localized
to the Golgi apparatus, plays a crucial role in
neuronal polarization [73] and vesicle trafficking
[74]. In polarized nascent neurons, Cdc42 is
distributed asymmetrically, and this distribution
depends on the presence of active Cdc42 in the
Golgi apparatus. The active Golgi-localized Cdc42
is transported to specific regions of the plasma
membrane to regulate cellular polarity [75]. The
absence of Cdc42 abrogates the reorientation
of the Golgi apparatus and alters cell polarity.
Following reelin treatment, Cdc42 is activated,
leading to the translocation of the dendritic
Golgi apparatus and promotion of neuronal
development [72, 76].
5.3 Therapies aimed at rescuing Golgi-mediated
membrane trafficking
Defects in Golgi-mediated membrane trafficking
Journal of Neurorestoratology
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are a hallmark of many neurodegenerative
disorders [77]. In an in vitro model of early-stage
epilepsy, the collapse of the ER–lysosome–Golgi
network resulted in decreased reelin processing,
which may contribute to the initiation and
propagation of seizures [27]. Thus, restoring this
network could be a novel therapeutic strategy
for attenuating epilepsy. In animal models of
Parkinson’s disease, blockage of ER-to-Golgi
membrane trafficking via alpha-synuclein
(αSyn) is a critical cellular lesion contributing
to dopaminergic neuronal degeneration [78].
Elevated expression of Rab1, a protein mediating
ER-to-Golgi membrane trafficking, can protect
against αSyn-induced dopaminergic neuronal
loss [79] and improve their survival to control
motor function [80]. A disintegrin and metalloproteinase 10 (ADAM10) is the major α-secretase
that controls amyloid precursor protein shedding
in the brain and restricts β-amyloid peptide
formation in Alzheimer’s disease [81]. ADAM10
trafficking from the dendritic Golgi outposts
to the synaptic membranes is a key modulator
of its activity. Increasing ADAM10 activity via
regulating synaptic trafficking may be efficacious
for treating Alzheimer’s disease [82, 83].

6

Summary

Accumulating evidence has identified the Golgi
apparatus as a central signaling hub between
the exocytic and endocytic routes of membrane
trafficking. Collectively, the reported findings
assert that the Golgi apparatus exerts potent
neurorestorative effects by contributing to
neurogenesis, synaptogenesis, and angiogenesis.
Multiple functions of the Golgi apparatus in
neurorestoration provide multiple therapeutic
targets for neurodegenerative diseases. However,
additional research investigating the complex
association between the Golgi apparatus and
neurorestoration is still warranted given that its
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involvement in neurorestoration remained to be
investigated systematically.
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